Systemic lupus erythematosus
Conditions
Interventions
Observational study - retrospective cohort using interviews and chart reviews. 190 systemic erythematosus lupus patients through 11 years (2006-2017) in order to better understand the factors related
Other
Sponsors
Universidade do Estado do Rio de Janeiro - Faculdade de Ciências Médicas
Universidade do Estado do Rio de Janeiro - Faculdade de Ciências Médicas
Eligibility
Sex/Gender
Female
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Systemic lupus erythematosus patients evaluated previously ten years ago and followed at the Hospital Universitário Pedro Ernesto.
Exclusion criteria
Exclusion criteria: Infection with HIV or HCV or HBV; or refusal to participate by the patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Damage accrual enhancement related to steroids burden evaluated by SLICC/ACR-DI. In order to confirm damage enhancement it is demanded an elevation by at least 1 point measured twice in approximately 10 years interval | — |
Secondary
| Measure | Time frame |
|---|---|
| Damage accrual enhancement related to azathioprine burden evaluated by SLICC/ACR-DI. In order to confirm damage enhancement it is demanded an elevation by 1 point at least measured twice in 10 years interval;Damage accrual enhancement related to mycophenolate burden evaluated by SLICC/ACR-DI. In order to confirm damage enhancement it is demanded an elevation by at least 1 point measured twice in approximately 10 years interval | — |
Countries
Brazil
Contacts
Public ContactRicardo Montes
Universidade do Estado do Rio de Janeiro - Faculdade de Ciências Médicas
Outcome results
None listed